Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.

× No keyword cloud information.

5 in total

1. Novel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertension.

Authors: Nilima Biswas; Jiaur Gayen; Manjula Mahata; Ying Su; Sushil K Mahata; Daniel T O'Connor
Journal: Hypertension Date: 2012-11-05 Impact factor: 10.190

2. Tetrapeptides on N- and C-terminal regions of mastoparan inhibit catecholamine release from chromaffin cells by blocking nicotinic acetylcholine receptor.

Authors: Noriyuki Monoi; Masaya Usui; Shunichi Takahashi; Hisashi Ito; Konosuke Kumakura; Hisataka Kasai
Journal: Cell Mol Neurobiol Date: 2004-02 Impact factor: 5.046

3. Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models.

Authors: Saiful A Mir; Kuixing Zhang; Milos Milic; Yusu Gu; Timo Rieg; Michael Ziegler; Sucheta M Vaingankar
Journal: J Hypertens Date: 2016-01 Impact factor: 4.844

4. Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential.

Authors: Eleonora Bassino; Sara Fornero; Maria Pia Gallo; Clara Gallina; Saveria Femminò; Renzo Levi; Bruno Tota; Giuseppe Alloatti
Journal: PLoS One Date: 2015-03-16 Impact factor: 3.240

5. Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia.

Authors: Weixian Xu; Haiyi Yu; Weihong Li; Wei Gao; Lijun Guo; Guisong Wang
Journal: PLoS One Date: 2016-06-15 Impact factor: 3.240

5 in total